Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis

BACKGROUND: Dyspnea is the hallmark symptom of pulmonary fibrosis. Supplemental oxygen (O(2)) is prescribed to many patients with pulmonary fibrosis in hopes of alleviating dyspnea and improving physical functioning. We used response data from the University of California San Diego Shortness of Brea...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Pulm Med
Päätekijät: Olson, Amy L., Graney, Bridget, Baird, Susan, Churney, Tara, Fier, Kaitlin, Korn, Marjorie, McCormick, Mark, Sprunger, David, Vierzba, Thomas, Wamboldt, Frederick S., Swigris, Jeffrey J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700736/
https://ncbi.nlm.nih.gov/pubmed/29166901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0497-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia